What is the mechanism of omeprazole (proton pump inhibitor) inducing Stevens-Johnson syndrome and what is the typical dose associated with this adverse reaction?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Omeprazole-induced Stevens-Johnson syndrome is an extremely rare but potentially life-threatening adverse reaction, and the typical dose associated with this reaction is not well-established, as it can occur at any dose, even after just 1-3 doses. The mechanism of this reaction is thought to involve an immune system overresponse, where T-cells attack skin cells, causing widespread blistering and mucosal damage 1. This severe allergic reaction typically occurs within the first 8 weeks of treatment, though it can develop at any point during treatment. The reaction is often preceded by a flu-like illness, followed by a painful rash, blistering, and skin detachment.

Key Points to Consider

  • Risk factors for omeprazole-induced Stevens-Johnson syndrome include genetic predisposition, prior drug reactions, and compromised immune function.
  • Symptoms of Stevens-Johnson syndrome include flu-like illness, painful rash, blistering, and skin detachment.
  • If Stevens-Johnson syndrome is suspected, omeprazole should be immediately discontinued and emergency medical care sought.
  • Treatment focuses on supportive care, wound management, and sometimes immunosuppressive therapy, as recommended in guidelines such as the U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 1.

Important Considerations for Management

  • Gastric protection with a proton pump inhibitor, such as omeprazole, is actually recommended in the management of Stevens-Johnson syndrome/toxic epidermal necrolysis, in patients who are at risk of stress-related gastric or duodenal ulceration 1.
  • However, given the potential risk of omeprazole-induced Stevens-Johnson syndrome, alternative proton pump inhibitors or histamine-2 receptor antagonists may be considered in patients who are at high risk of this adverse reaction.

From the Research

Mechanism of Omeprazole Inducing Stevens-Johnson Syndrome

  • There is no direct evidence in the provided studies that explains the mechanism of omeprazole (proton pump inhibitor) inducing Stevens-Johnson syndrome 2, 3, 4, 5, 6.
  • The studies primarily focus on other medications such as trimethoprim-sulfamethoxazole, allopurinol, carbamazepine, and phenytoin, which are associated with Stevens-Johnson syndrome.

Typical Dose Associated with Adverse Reaction

  • The provided studies do not mention the typical dose of omeprazole associated with Stevens-Johnson syndrome 2, 3, 4, 5, 6.
  • The studies discuss the association of various medications with Stevens-Johnson syndrome but do not provide information on the dosage of omeprazole.

Associated Medications

  • The studies identify several medications that are associated with Stevens-Johnson syndrome, including:
    • Trimethoprim-sulfamethoxazole 2
    • Allopurinol 3, 6
    • Carbamazepine 3, 4, 6
    • Phenytoin 3, 4, 6
  • However, omeprazole is not mentioned as a medication associated with Stevens-Johnson syndrome in the provided studies 2, 3, 4, 5, 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.